EDAP TMS SA, the global leader in robotic energy-based therapies, today announced that it will host a key opinion leader (KOL) call on its two lead commercial products, Focal One® and ExactVu™, on Tuesday, September 22nd at 8am Eastern Time.
The call will feature a presentation by Key Opinion Leaders (KOL) Brian Miles, MD (Houston Methodist) and Laurence Klotz, MD (Sunnybrook Health Sciences Centre) who will discuss the opportunity for the Focal One® High Intensity Focused Ultrasound (HIFU) system and the ExactVu™ micro-ultrasound. Drs. Miles and Klotz will be available to answer questions at the conclusion of the call.
EDAP TMS’s management team will also give an update on the sales successes they are seeing for both stand-alone solutions as well as bundled deals, as well as the additional pipeline expansion opportunities that exist for these technologies beyond prostate cancer.
By combining the latest imaging and ablation technologies, Focal One® brings the answer to current requirements for ideal focal therapy: accurate MRI and 3D Biopsy image fusion, non-invasive approach, as well as precise and efficient HIFU energy. This is the industry’s first end-to-end solution for the urology suite.
The ExactVu™ micro-ultrasound platform provides the most practical solution as a new tool for urologists or radiologists to perform targeted biopsies within a standard urological workflow and is the only ultrasound-based imaging tool with published data demonstrating prostate cancer diagnostic capabilities similar to MRI. The unique 29MHz frequency allows urologists to visualize details unseen before in any prostate ultrasound image, detect suspicious areas in real-time and take a biopsy sample as representative of the level of aggressiveness of the cancer.